| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051098711 |
| P356 | DOI | 10.1007/BF02726191 |
| P8608 | Fatcat ID | release_fxoq6pzk4bg6zeop6ghktxfho4 |
| P698 | PubMed publication ID | 10832243 |
| P2093 | author name string | Warner J | |
| Legg J | |||
| P2860 | cites work | Methotrexate treatment of severe asthma in children | Q28319366 |
| Recent advances in our understanding of the use of theophylline in the treatment of asthma | Q33540339 | ||
| Time trends in respiratory symptoms in childhood over a 24 year period | Q33623480 | ||
| Liberation of histamine and formation of lysocithin-like substances by cobra venom | Q34568156 | ||
| Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study | Q34616592 | ||
| Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma | Q34663389 | ||
| Prevalence of asthma in Melbourne schoolchildren: changes over 26 years | Q35179364 | ||
| Effects of time, sex, ethnic origin, and area of residence on prevalence of asthma in Israeli adolescents | Q35189674 | ||
| The use of cyclosporin in corticosteroid dependent asthma | Q35257675 | ||
| Changes in asthma prevalence: two surveys 15 years apart | Q35626097 | ||
| Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC) | Q77199721 | ||
| Increasing asthma prevalence in a rural New Zealand adolescent population: 1975-89 | Q35626708 | ||
| Cyclosporine | Q38733507 | ||
| Salmeterol xinafoate in children on high dose inhaled steroids | Q39471068 | ||
| Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy. | Q39473939 | ||
| Prevalence of asthma in Finnish young men. | Q39933743 | ||
| Mechanisms of action of intravenous immune serum globulin therapy | Q40561677 | ||
| Functional antagonism: tolerance produced by inhaled beta 2 agonists | Q41207925 | ||
| Phosphodiesterase isozymes: molecular targets for novel antiasthma agents | Q41708863 | ||
| The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects | Q42549430 | ||
| Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group | Q42556993 | ||
| Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody | Q42943416 | ||
| Use of methotrexate in the treatment of steroid-dependent adolescent asthmatics | Q44942674 | ||
| Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma | Q45296274 | ||
| Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. | Q46001868 | ||
| Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma | Q46488895 | ||
| The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics | Q47696616 | ||
| Attenuation of inhaled allergen-induced airway microvascular leakage and airflow obstruction in guinea pigs by a 5-lipoxygenase inhibitor (A-63162). | Q50803915 | ||
| Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma. | Q52918745 | ||
| Treatment of asthma with drugs modifying the leukotriene pathway. | Q53474242 | ||
| Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma | Q56864483 | ||
| Interleukin-5 and allergic inflammation | Q61892550 | ||
| Trial of cyclosporin in corticosteroid-dependent chronic severe asthma | Q67513391 | ||
| Methotrexate in bronchial asthma | Q67698465 | ||
| Cyclosporin for steroid-dependent asthma | Q67980996 | ||
| The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air | Q68613879 | ||
| Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls | Q68891371 | ||
| An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma | Q70147096 | ||
| Bronchoconstrictor effects of leukotriene C in humans | Q70298182 | ||
| Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids | Q71078827 | ||
| Efficacy and safety of salmeterol in childhood asthma | Q71520269 | ||
| Secretogogue responses of leukotriene C4, D4: comparison of potency in canine trachea in vivo | Q71749865 | ||
| Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group | Q71823499 | ||
| Beta-adrenergic bronchodilators | Q71927119 | ||
| Salmeterol does not cause tolerance during long-term asthma therapy | Q71930961 | ||
| Effects of an antibody to interleukin-5 in a monkey model of asthma | Q71954025 | ||
| Inhibitory effect of cyclosporin A on eosinophil infiltration in the guinea-pig lung induced by antigen, platelet-activating factor and leukotriene B4 | Q72106933 | ||
| The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma | Q72605042 | ||
| Blockade of eosinophil migration by 5-lipoxygenase and cyclooxygenase inhibition in explanted guinea pig trachealis | Q72655377 | ||
| The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects | Q73442941 | ||
| Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response | Q73442944 | ||
| Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients: a meta-analysis | Q73521526 | ||
| Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses | Q73528566 | ||
| One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group | Q73730724 | ||
| Prospective, double-blind, placebo-controlled, multicentre study on the effect of high-dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma | Q74355289 | ||
| Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group | Q74471633 | ||
| Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol | Q74593927 | ||
| Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group | Q74761187 | ||
| P433 | issue | 2 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 147-153 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Indian Journal of Pediatrics | Q26842079 |
| P1476 | title | Asthma--the changing face of drug therapy | |
| P478 | volume | 67 |
Search more.